Some countries like; Denmark, Norway, Austria, Italy and more have suspended the use of the AstraZeneca vaccine, following severe negative reactions to the vaccine by some persons.
It was observed that some vaccinated persons suffered from blood coagulations, blot clot, severe complications and even death. The batch sent to Austria (ABV5300) was reportedly sent to at least seventeen (17) European countries.
Recall that Nigeria received over 3.9 million doses of the AstraZeneca vaccine early last week and many politicians and prominent persons have publicly taken the vaccine.
Yesterday, the National Primary Health Care Development Agency (NPHCDA) stated that Nigeria has not observed any adverse reactions to the Oxford-AstraZeneca vaccine and that the batch suspended by some countries was different from what the country got.
NPHCDA, in a statement released via its official handle said:
“We understand that investigations are being conducted to determine if the batch is in any way linked to an observed side effect.
We are satisfied that the clinical evidence indicates the Oxford-AstraZeneca vaccine to be safe and effective.
While we await the outcome of the investigations, it is important to clearly state that Nigeria did not receive any doses from the batch of vaccines which is in issue.
Our assessment is in line with countries such as Spain and the UK who have indicated that they will continue to administer the vaccine, because it remains an important tool to protect against COVID-19.
The safety of vaccines delivered to Nigeria is paramount to the Presidential Task Force on COVID-19.
For this reason, it has enhanced multi-sectoral collaboration among stakeholders and technical entities such as the FMOH, NPHCDA, NAFDAC, WHO and UNICEF.”
The agency encouraged Nigerians not to loose confidence in the vaccine, as the drug’s safety had been studied extensively in various clinical trials.